News headlines about BIO-key International (NASDAQ:BKYI) have trended positive recently, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. BIO-key International earned a daily sentiment score of 0.31 on Accern’s scale. Accern also gave news coverage about the technology company an impact score of 44.6209170745607 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Separately, Maxim Group reiterated a “buy” rating and issued a $5.50 price objective on shares of BIO-key International in a research note on Thursday, December 21st.
BIO-key International (NASDAQ BKYI) traded down $0.07 during midday trading on Tuesday, hitting $2.12. 10,479 shares of the stock were exchanged, compared to its average volume of 44,913. BIO-key International has a 52 week low of $1.20 and a 52 week high of $3.67.
About BIO-key International
BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver’s licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing.
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.